Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00524355

NIS-GVN-NEX-2007/1

NIS-G84-GER-2007/2

Details and patient eligibility

About

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)

Enrollment: 2,717 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients from both sexes, aged 18 years or older
• Patients complaining of symptoms consistent with reflux disease

Exclusion criteria

• Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded